THE USE OF 5 FLUOROURCIL, DELIVERED BY INOTOPHORESIS AS AN INHIBITOR OF CELL PROLIFERATION IN THE EYE, BULBAR AND PALPEBRAL CONJUNCTIVA, EYELID, PERI-ORBITAL SOFT TISSUES AND SKIN - Patent 1418919

(19)

(11)

EP 1 418 919 A2

(12)

(88)	Date of publication A3:
	19.06.2003

(43)	Date of publication:
	19.05.2004 Bulletin 2004/21

(21)	Application number: 02747054.1

(22)	Date of filing: 19.07.2002

(51)	International Patent Classification (IPC)⁷: A61K 31/55

(86)	International application number:
	PCT/US2002/022860

(87)	International publication number:
	WO 2003/007798 (30.01.2003 Gazette 2003/05)

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

20.07.2001 US 306788 P

(71)	Applicant: IOMED, INC.
	Salt Lake City,Utah 84104 (US)

(72)	Inventors:
	WARREN, Stephen Salt Lake City, UT 84121 (US) HAMILTON, Steven Park City, UT 84098 (US)

(74)	Representative: Ostertag, Ulrich, Dr. et al
	PatentanwälteDr. Ulrich OstertagDr. Reinhard OstertagEibenweg 10 70597 Stuttgart 70597 Stuttgart (DE)

(54)	THE USE OF 5 FLUOROURCIL, DELIVERED BY INOTOPHORESIS AS AN INHIBITOR OF CELL PROLIFERATION IN THE EYE, BULBAR AND PALPEBRAL CONJUNCTIVA, EYELID, PERI-ORBITAL SOFT TISSUES AND SKIN